Harvest One Cannabis Inc. (TSXV:HVST) through its wholly owned subsidiary United Greeneries is pleased to announce the launch of retail sales beginning February 2018;
Cannabis News
Vermont House votes to legalize marijuana
The Vermont House passed a bill Thursday night to legalize recreational possession of marijuana just hours after Attorney General Jeff Sessions rescinded a Department of Justice policy on legal marijuana.
Aurora Cannabis to be Cornerstone Investor in The Green Organic Dutchman and Signs Supply Agreement for Organic Cannabis
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and The Green Organic Dutchman Holdings Ltd. ("TGOD") (privately held) today announced that the companies have completed a definitive agreement covering a strategic investment in TGOD by Aurora, as well as a supply contract.
Canopy Growth Corporation Responds to Department of Justice Update on U.S. Cannabis Laws
In response to news out of the United States Department of Justice yesterday morning regarding federal cannabis laws in the United States and further to press releases issued Oct 17, 2017 and Aug. 4, 2017, Canopy Growth Corporation (TSX: WEED) wishes to reiterate its commitment to only conducting business in jurisdictions where that conduct is federally legal and otherwise in compliance with all applicable laws.
Liberty Health Sciences Raises $15 Million via Bought Deal
Liberty Health Sciences Inc. (CSE:LHS)(CSE:LHS.CN)(CNSX:LHS) has today entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 7,142,900 units of the Company at a price of C$2.10 per Unit for aggregate gross proceeds to the Company of C$15,000,090.
Aurora Cannabis Announces $200 Million Bought Deal Financing
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has entered into an agreement with a syndicate of underwriters, led by Canaccord Genuity Corp., pursuant to which Canaccord Genuity has agreed to purchase, on a bought deal basis, 200,000 convertible debentures, at a price of $1,000 per Initial Convertible Debenture, for gross proceeds of $200 million.
ABcann Adds Big Alcohol Expertise with New Chief Marketing Officer
ABCANN GLOBAL CORPORATION (TSX-V:ABCN) is pleased to announce the appointment of Sung Kang as the Company's Chief Marketing Officer (CMO). Mr. Kang, who will assume the position effective January 8, 2018, was formerly the Head of Marketing for the Mike’s Beverage Company, Canada’s leading ready-to-drink and cider business, owned by Labatt Breweries of Canada.
INMED CLOSES OVER-SUBSCRIBED C$9.4 MILLION FINANCING
InMed Pharmaceuticals, Inc. (CSE:IN; OTCQB: IMLFF), has closed its previously announced non-brokered private placement for gross proceeds of C$9.4 Million through the issuance of 13,428,571 units, with terms as previously announced on December 18, 2017.
Aurora Cannabis Accelerates European Expansion With Licensed Denmark Joint Venture
Planned 1,000,000 Square Foot High-Tech Facility Will Establish "Aurora Nordic Cannabis" as Europe's Largest Cannabis Producer
Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd., whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida.
Sessions to rescind Obama-era rules on non-interference with states where pot is legal
In a seismic shift, Attorney General Jeff Sessions will announce Thursday that he is rescinding a trio of memos from the Obama administration that adopted a policy of non-interference with marijuana-friendly state laws.
ABcann Global Announces Receipt of Health Canada License to Produce Cannabis Oils
ABCANN GLOBAL CORPORATION (TSX-V:ABCN) is pleased to announce that the Company has been licensed by Health Canada to produce medical cannabis oils.
Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale
Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor under which the Investor has agreed, subject to certain customary conditions, to purchase 3,000,000 units of the Company at a price of $5.00 per Unit for total gross proceeds of $15,000,000.
Aurora Cannabis Calls for Additional Disclosure from CanniMed on "Bizarre" Newstrike Supply Agreement
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today called for additional disclosure on yesterday'announcement by CanniMed Therapeutics Inc. of a supply agreement with Up Cannabis Inc., a subsidiary of Newstrike Resources Ltd, CanniMed's proposed acquisition candidate.
Emblem Corp. and Dosecann Inc. Sign Licensing Deal to Develop Dosage-Controlled Formulations
Emblem Corp. (TSX-V:EMC) (EMC.WT), has entered into a licensing agreement with Dosecann Inc. pursuant to which Dosecann will begin developing a range of cannabinoid dosage formulations designed to ensure patients are better able to titrate and administer each dose the exact same way.